The BHC program is an inexpensive, interactive, multi-modal health coaching approach, that assists patients in adopting consensus-based brain health recommendations. It was tested in a 6-month, single-centre, randomised controlled trial of 40 patients with dementia, MCI, or subjective cognitive decline. In the active intervention arm, a BHC was added to the clinical team who made weekly motivational phone call interviews and additional in-person visits every 6 weeks. BHCs and patients/caregivers also met to establish and update personalised, attainable goals. Primary outcomes were changes in physical activity, dietary pattern, and cognitive/social engagement.
BHC participants had statistically significant and clinically meaningful increases in brain-healthy behaviour scores and quality of life compared to the standard-of-care control group. Cohenās d effect sizes were in the large to very large range for:
- physical activity (d=1.37, P<0.001);
- Mediterranean diet (d=0.87, P=0.016);
- cognitive and social activity (d=1.09, P=0.003);
- quality of life (d=1.54, P<0.001).
BHCs helped participants access existing, cost-effective, community-based resources to achieve their goals.
1. Gale S, et al. AAN 2019, S9.003.
Posted on
Previous Article
« Interview with Prof. Natalia Rost Next Article
Brain-responsive neurostimulation reduces seizures »
« Interview with Prof. Natalia Rost Next Article
Brain-responsive neurostimulation reduces seizures »
Table of Contents: AAN 2019
Featured articles
Letter from the Editor
Interview with Prof. Natalia Rost
Alzheimer's Disease and other Dementias
Amyloid PET in cognitively impaired patients
Tight blood pressure control lowers risk of mild cognitive impairment
Epilepsy
Headache and Migraine
Multiple Sclerosis and NMOSD
Immune tolerance by peptide-loaded tolerogenic dendritic cells
Biotin, ocrelizumab, and ibudilast in progressive MS
No increased MS relapse risk postpartum
Neuromuscular Disorders
First-ever effective and safe treatment of CMT1A
Parkinsonās Disease and other Movement Disorders
Leukaemia and hypertension therapies tested in Parkinson’s disease
Stroke
Miscellaneous
Possibly lifesaving therapy in refractory PML
New AAN guideline for treating Tourette syndrome
Subspecialty teleneurology: feasible and highly valued
Related Articles
Ā© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com